PRC Clinical at Outsourcing in Clinical Trials Israel

San Bruno, CA. March 2, 2015. PRC Clinical, a full-service, Contract Research Organization (CRO) headquartered in the San Francisco Bay Area, will exhibit and present at the Outsourcing in Clinical Trials (OCT) Israel Conference 2015 on March 25th and 26th in Tel Aviv, Israel.

PRC Clinical seeks to build relationships with Israeli life science companies seeking to conduct U.S. Food and Drug Administration (FDA) clinical trials. The company’s services span all phases of human trials, from Phase I studies in healthy subjects, through to Phase II, dose-finding and safety studies to larger Phase III and post-marketing studies.

Israel is one of the major emerging markets in terms of healthcare and pharmaceuticals worldwide. According to the Israeli Ministry of Economy, Israel is the fourth largest supplier of pharmaceutical products to the U.S. market. “We are familiar with the Israeli and U.S. drug development industry and regulatory requirements,” said Tony Taricco, President and Chief Operating Officer at PRC Clinical. “We have significant CRO experience conducting trials from early phase through to regulatory submission across a wide range of different therapeutic areas.”

PRC Clinical will present its clinical services at the event, along with its partner, Statistics & Data Corporation (SDC). SDC offers biostatistics and clinical data management services to pharmaceutical, biotechnology, medical device companies, and CROs. “Our strategic alliance with SDC allows us to offer best-in-class, full-service solutions to better meet the clinical trial needs of Israeli sponsors,” said Curtis Head, Chief Executive Officer at PRC Clinical.

PRC Clinical has the experience and regulatory knowledge to support Israeli sponsors planning to conduct US-based clinical trials. Last year, BrainStorm Cell Therapeutics (NASDAQ:BCLI), an Israel-based biotechnology company developing adult stem cell therapies for debilitating neurodegenerative disorders, engaged PRC Clinical as its CRO to support its ongoing U.S. clinical program. PRC Clinical was selected based on the company’s strong experience conducting orphan drug trials in neurology, specifically in the area of amyotrophic lateral sclerosis (ALS).

If you would like to arrange to meet with a PRC Clinical representative at the OCT Israel Conference in Tel Aviv, please contact us at

About PRC Clinical

PRC Clinical™ is a full-service CRO headquartered in the San Francisco Bay Area offering clinical trial- management services to drug and medical device sponsors. PRC delivers the highest quality results in the industry, and has the capabilities and expertise to handle the most complex clinical trials. PRC has served sponsors in all phases of clinical studies from orphan drug trials to large clinical registries globally. We are therapeutically diverse and experienced with innovative treatment modalities from regenerative stem-cell technologies to cutting-edge medical devices. Services include clinical operations, project and site management, regional monitoring, medical and safety monitoring, Eclipse™ clinical payment services, CTMS, protocol design and development, IND preparation and filing, clinical laboratory services, medical writing, and consulting. For more information, call (1-877-519-6001) or e-mail

About Statistics & Data Corporation (SDC)

Statistics & Data Corporation (SDC) provides innovative biostatistics and clinical data management services to pharmaceutical, biotechnology, and medical device companies, as well as CRO partners. SDC is committed to providing experienced teams who will take ownership of their clients’ needs and are positively engaged in their projects. Incorporated in 2005 and headquartered in Tempe, AZ, SDC has successfully supported over 150 clinical trials across various therapeutic areas.

About BrainStorm Cell Therapeutics Inc.

BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The company holds the rights to develop and commercialize its NurOwn™ technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University. NurOwn™ has been administered to over 30 patients with ALS in clinical trials conducted in Israel, and is currently being studied in a randomized, double-blind, placebo-controlled clinical trial in the United States.

About Arena International, Outsourcing in Clinical Trials (OCT) Conference

Outsourcing in Clinical Trials (OCT) Israel is part of Outsourcing in Clinical Trials (OCT) series organized by Arena International. Arena international’s events are designed to help senior business people do business, to formulate a proactive approach to perfecting Sponsor-Vendor relationships. Each year, over 10,000 business executives from Fortune 1000 companies attend over 80 Arena International events worldwide, addressed by over 1,700 industry leaders delivering leading edge content and discussion.